All Stories

  1. Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson’s Disease: Pulsatile versus Continuous Dopaminergic Stimulation

    Article • Journal of Parkinson’s Disease, April 2020, IOS Press

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  2. Levodopa after 60 years: still a gold standard drug, with so many formulations to use.

    Article • Current Neuropharmacology, August 2018, Bentham Science Publishers

    Dr Nicola Tambasco, Michele Romoli, Dr. Nicola Tambasco

  3. Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients

    Article • Movement Disorders, August 2017, Wiley

    Dr Nicola Tambasco, Paolo Eusebi, Lucilla Parnetti, Dr. Nicola Tambasco

  4. Morning akinesia in Parkinson's disease: challenges and solutions

    Article • Journal of Parkinsonism and Restless Legs Syndrome, June 2016, Dove Medical Press

    Dr Nicola Tambasco, Dr. Simone Simoni, Pasquale Nigro

  5. Imaging synucleinopathies

    Article • Movement Disorders, February 2016, Wiley

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  6. Prognostic factors in children with PRES and hematologic diseases

    Article • Acta Neurologica Scandinavica, February 2016, Wiley

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  7. CSF levels of heart fatty acid binding protein in Parkinson's and Alzheimer's disease

    Article • Parkinsonism & Related Disorders, January 2016, Elsevier

    Dr Nicola Tambasco

  8. Magnetization transfer MRI in dementia disorders, Huntington's disease and parkinsonism

    Article • Journal of the Neurological Sciences, June 2015, Elsevier

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  9. The validation of an Italian version of the Freezing of Gait Questionnaire

    Article • Neurological Sciences, December 2014, Springer Science + Business Media

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  10. Diagnostic Accuracy of Parkinson Disease by Support Vector Machine (SVM) Analysis of 123I-FP-CIT Brain SPECT Data

    Article • Medicine, December 2014, Wolters Kluwer Health

    Dr Nicola Tambasco, Barbara Palumbo, Dr. Nicola Tambasco

  11. Subclinical Visuospatial Impairment in Parkinson’s Disease: The Role of Basal Ganglia and Limbic System

    Article • Frontiers in Neurology, August 2014, Frontiers

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  12. Shapiro's syndrome: Defining the clinical spectrum of the spontaneous paroxysmal hypothermia syndrome

    Article • European Journal of Paediatric Neurology, July 2014, Elsevier

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  13. Factors Influencing the Measurement of Lysosomal Enzymes Activity in Human Cerebrospinal Fluid

    Article • PLoS ONE, July 2014, PLOS

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  14. Entacapone Reduces Cortical Activation in Parkinson's Disease with Wearing-Off: A f-MRI Study

    Article • PLoS ONE, May 2014, PLOS

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  15. Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease

    Article • Frontiers in Aging Neuroscience, March 2014, Frontiers

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  16. Cerebrospinal fluid lysosomal enzymes and alpha‐synuclein in Parkinson's disease

    Article • Movement Disorders, January 2014, Wiley

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  17. Complexity of Motor Sequences and Cortical Reorganization in Parkinson's Disease: A Functional MRI Study

    Article • PLoS ONE, June 2013, PLOS

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  18. Cerebrospinal fluid biomarkers in Parkinson disease

    Article • Nature Reviews Neurology, February 2013, Nature

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  19. The validity and reliability of the Italian Olfactory Identification Test (IOIT) in healthy subjects and in Parkinson's disease patients

    Article • Parkinsonism & Related Disorders, July 2012, Elsevier

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  20. Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale

    Article • Neurological Sciences, June 2012, Springer Science + Business Media

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  21. Coenzyme Q10, Hyperhomocysteinemia and MTHFR C677T Polymorphism in Levodopa-treated Parkinson’s Disease Patients

    Article • NeuroMolecular Medicine, February 2012, Springer Science + Business Media

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  22. Clinical Aspects and Management of Levodopa-Induced Dyskinesia

    Article • Parkinson s Disease, January 2012, Hindawi Publishing Corporation

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  23. Role of Lysosomal Enzymes in Parkinson’s Disease: Lesson from Gaucher’s Disease

    Article • October 2011, IntechOpen

    Dr Nicola Tambasco

  24. CFS Biomarkers in Parkinson’s Disease

    Article • September 2011, IntechOpen

    Dr Nicola Tambasco

  25. Recurrent hypothermia with hyperhidrosis in two siblings: familial Shapiro syndrome variant

    Article • Journal of Neurology, September 2011, Springer Science + Business Media

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  26. Levodopa-induced breathing, cognitive and behavioral changes in Parkinson’s disease

    Article • Journal of Neurology, June 2011, Springer Science + Business Media

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  27. Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias

    Article • Movement Disorders, April 2011, Wiley

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  28. Levetiracetam in brain ischemia: Clinical implications in neuroprotection and prevention of post-stroke epilepsy

    Article • Brain and Development, April 2011, Elsevier

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  29. Decreased Contralateral Putamen [123I]FP-CIT SPECT Uptake in Hyperglycemic Hemichorea-Hemiballismus

    Article • European Neurology, January 2011, Karger Publishers

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  30. Ictal Epileptic Headache Mimicking Status Migrainosus: EEG and DWI-MRI Findings

    Article • Headache The Journal of Head and Face Pain, January 2011, Wiley

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  31. Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap

    Article • The Lancet Neurology, November 2010, Elsevier

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  32. Heterozygous X-linked adrenoleukodystrophy-associated myelopathy mimicking primary progressive multiple sclerosis

    Article • Journal of Neurology, August 2010, Springer Science + Business Media

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  33. Vomiting due to intravenous levetiracetam in a case of Creutzfeldt–Jakob disease

    Article • Epilepsy & Behavior, January 2010, Elsevier

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  34. A young patient with type C multiple system atrophy and hereditary hemochromatosis

    Article • Journal of Neurology, October 2009, Springer Science + Business Media

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  35. Hot water epilepsy and Mccune–Albright syndrome: A case report

    Article • Seizure, March 2009, Elsevier

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  36. Rapid effect of levetiracetam in a case of juvenile myoclonic epilepsy

    Article • Epilepsy & Behavior, January 2009, Elsevier

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  37. Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies

    Article • Biological Psychiatry, November 2008, Elsevier

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  38. Nerve growth factor and brain-derived neurotrophic factor: potential targets for migraine treatment?

    Article • Expert Opinion on Therapeutic Patents, June 2008, Informa Healthcare

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  39. Acute dystonia induced by the combination of midodrine and perphenazine

    Article • Journal of Neurology, March 2008, Springer Science + Business Media

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  40. Parkinsonism and cognitive impairment following chronic exposure to potassium cyanide

    Article • Movement Disorders, December 2007, Wiley

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  41. Occipital pseudoaneurysm as a complication of extension channel placement for DBS in Parkinson's disease

    Article • Movement Disorders, January 2007, Wiley

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  42. Prevalence of essential tremor in the territory of Lake Trasimeno, Italy: Results of a population-based study

    Article • Movement Disorders, January 2007, Wiley

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  43. Characteristics of Delayed Admission to Stroke Unit

    Article • Clinical and Experimental Hypertension, January 2006, Taylor & Francis

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  44. Efficacy of Thrombolytic (rt-PA) Therapy in Old Stroke Patients: The Perugia Stroke Unit Experience

    Article • Clinical and Experimental Hypertension, January 2006, Taylor & Francis

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  45. Multimodal Use of Computed Tomography in Early Acute Stroke, Part 1

    Article • Clinical and Experimental Hypertension, January 2006, Taylor & Francis

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  46. Cardiac pacing: atrial fibrillation may go unrecognised

    Article • The Lancet Neurology, May 2005, Elsevier

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  47. A case of vertebrobasilar stroke during oxygen-ozone therapy

    Article • Journal of Stroke and Cerebrovascular Diseases, November 2004, Elsevier

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  48. BRAIN CT-SCAN IN ACUTE STROKE PATIENTS: SILENT INFARCTS AND RELATION TO OUTCOME

    Article • Clinical and Experimental Hypertension, January 2002, Taylor & Francis

    Dr Nicola Tambasco, Dr. Nicola Tambasco

  49. BRAIN CT SCAN IN ACUTE ISCHEMIC STROKE: EARLY SIGNS AND FUNCTIONAL OUTCOME

    Article • Clinical and Experimental Hypertension, January 2002, Taylor & Francis

    Dr Nicola Tambasco, Dr. Nicola Tambasco